May 07, 2020
Applied DNA Schedules Fiscal 2020 Second Quarter Financial Results Conference Call for Thursday, May 14, 2020 at 4:30 PM ET
May 06, 2020
Applied DNA Receives Approximately $5.3 Million in Net Proceeds from Warrant Exercise
Apr 30, 2020
Applied DNA Accepted Into U.S. FDA’s Emerging Technology Program, Creating Pathway for Molecular Tagging of Pharmaceuticals and Packaging
Apr 14, 2020
Applied DNA to Speak on COVID-19 Panel at Maxim Group’s Infectious Disease Virtual Conference on May 5
Apr 02, 2020
Applied DNA and Takis Biotech Expand COVID-19 Vaccine Development Program to Include 5th Candidate
Mar 20, 2020
Applied DNA Secures Global Top-20 Pharmaceutical Manufacturer as Drug Development Customer
Feb 24, 2020
Applied DNA Announces Receipt of International Patents on its Beacon® Secure Optical Molecular Marker Technologies
Feb 07, 2020
Applied DNA Announces Issuance of U.S. Patent Protecting its CertainT® Platform in Man-Made Cellulosic Fibers and Materials
Jan 30, 2020
Applied DNA Schedules Fiscal 2020 First Quarter Financial Results Conference Call for Thursday, February 6, 2020 at 4:30 PM ET
Jan 27, 2020
Applied DNA Announces Issuance of U.S. Patent Protecting its CertainT® Platform in Man-Made Cellulosic Fibers and Materials
Dec 23, 2019
Colorcon, Inc. Launches On-Dose Authentication Platform From Applied DNA Sciences
Nov 26, 2019
Applied DNA Sciences Regains Compliance with Nasdaq Listing Standards
Nov 16, 2019
Applied DNA Sciences Announces Closing of Upsized $12.0 Million Underwritten Public Offering
Oct 22, 2019
Applied DNA Receives Notice of Allowance on Patent Protecting its CertainT® Platform in Cellulosic Fibers and Materials
Oct 03, 2019
Applied DNA Receives Extension from Nasdaq
Sep 24, 2019
Applied DNA Receives $1 Million Order to Supply SigNature® T Molecular Taggant for 2019-2020 Cotton Harvest Season
Aug 06, 2019
Applied DNA Schedules Fiscal 2019 Third Quarter Financial Results Conference Call for Tuesday, August 13, 2019 at 4:30 PM ET
Apr 04, 2019
Applied DNA’s Platform Empowers President Trump’s Anti-Counterfeiting Memorandum Signed Today to Protect American Consumers and Industries
Feb 08, 2019
Applied DNA Reports Fiscal First Quarter 2019 Financial Results
Dec 28, 2018
Applied DNA Announces Closing of $2.75 Million Public Offering of Common Stock and Warrants